| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| NF-kappa B | 9 | 2023 | 355 | 1.620 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2016 | 184 | 1.540 |
Why?
|
| Tumor Necrosis Factor-alpha | 7 | 2016 | 379 | 1.290 |
Why?
|
| Blood Donors | 4 | 2022 | 20 | 1.130 |
Why?
|
| Sesquiterpenes | 3 | 2013 | 38 | 1.110 |
Why?
|
| Withanolides | 3 | 2016 | 10 | 1.020 |
Why?
|
| Plant Extracts | 10 | 2016 | 303 | 0.890 |
Why?
|
| Polygonatum | 1 | 2024 | 1 | 0.870 |
Why?
|
| Mannans | 1 | 2024 | 4 | 0.870 |
Why?
|
| Antineoplastic Agents, Phytogenic | 3 | 2017 | 134 | 0.850 |
Why?
|
| Hypoglycemic Agents | 2 | 2024 | 181 | 0.840 |
Why?
|
| Polysaccharides | 1 | 2024 | 70 | 0.820 |
Why?
|
| Liver Failure, Acute | 1 | 2023 | 5 | 0.820 |
Why?
|
| Lactones | 2 | 2013 | 22 | 0.810 |
Why?
|
| Vernonia | 2 | 2013 | 15 | 0.800 |
Why?
|
| Plants, Medicinal | 5 | 2010 | 60 | 0.770 |
Why?
|
| Molecular Structure | 12 | 2018 | 560 | 0.760 |
Why?
|
| STAT3 Transcription Factor | 4 | 2024 | 97 | 0.750 |
Why?
|
| Lipopolysaccharides | 5 | 2023 | 235 | 0.750 |
Why?
|
| Blood Glucose | 1 | 2024 | 386 | 0.730 |
Why?
|
| Nitric Oxide | 7 | 2016 | 381 | 0.690 |
Why?
|
| Mice | 18 | 2025 | 6490 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 3 | 2018 | 415 | 0.650 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2016 | 18 | 0.640 |
Why?
|
| Physalis | 2 | 2016 | 3 | 0.630 |
Why?
|
| Fruit | 3 | 2018 | 178 | 0.620 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2025 | 158 | 0.620 |
Why?
|
| Structure-Activity Relationship | 9 | 2018 | 491 | 0.600 |
Why?
|
| Garcinia | 1 | 2017 | 5 | 0.550 |
Why?
|
| Benzophenones | 1 | 2017 | 10 | 0.540 |
Why?
|
| Gardenia | 1 | 2016 | 1 | 0.520 |
Why?
|
| Disaccharidases | 1 | 2016 | 1 | 0.510 |
Why?
|
| Triterpenes | 1 | 2016 | 18 | 0.510 |
Why?
|
| Animals | 22 | 2025 | 16695 | 0.500 |
Why?
|
| Levivirus | 1 | 2016 | 2 | 0.500 |
Why?
|
| Morinda | 1 | 2016 | 9 | 0.500 |
Why?
|
| Humans | 39 | 2025 | 42163 | 0.490 |
Why?
|
| Hyperthermia, Induced | 1 | 2016 | 27 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 744 | 0.480 |
Why?
|
| Chaetomium | 1 | 2015 | 2 | 0.480 |
Why?
|
| Macrophages | 3 | 2025 | 515 | 0.480 |
Why?
|
| Benzopyrans | 1 | 2015 | 25 | 0.470 |
Why?
|
| Apoptosis | 5 | 2024 | 1541 | 0.460 |
Why?
|
| Collagen | 1 | 2016 | 178 | 0.460 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 147 | 0.450 |
Why?
|
| Drug Resistance, Microbial | 1 | 2014 | 26 | 0.430 |
Why?
|
| Peptide Fragments | 1 | 2016 | 301 | 0.430 |
Why?
|
| Streptomyces | 1 | 2014 | 20 | 0.430 |
Why?
|
| Purine Nucleosides | 1 | 2014 | 15 | 0.430 |
Why?
|
| Moringa oleifera | 2 | 2011 | 2 | 0.420 |
Why?
|
| Carbazoles | 1 | 2014 | 46 | 0.420 |
Why?
|
| Microbial Sensitivity Tests | 4 | 2018 | 232 | 0.420 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 273 | 0.410 |
Why?
|
| China | 4 | 2022 | 233 | 0.410 |
Why?
|
| Sulfonamides | 1 | 2014 | 88 | 0.410 |
Why?
|
| Arabidopsis | 2 | 2025 | 102 | 0.400 |
Why?
|
| Withania | 1 | 2013 | 6 | 0.400 |
Why?
|
| Indoles | 1 | 2014 | 178 | 0.390 |
Why?
|
| Circadian Rhythm | 2 | 2025 | 234 | 0.380 |
Why?
|
| Inflammation | 2 | 2024 | 729 | 0.370 |
Why?
|
| Hepatitis B, Chronic | 2 | 2022 | 16 | 0.360 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2018 | 1112 | 0.360 |
Why?
|
| Immunoglobulin M | 2 | 2022 | 87 | 0.350 |
Why?
|
| Mice, Nude | 3 | 2024 | 403 | 0.340 |
Why?
|
| Cell Line | 5 | 2016 | 1416 | 0.330 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 253 | 0.330 |
Why?
|
| Peroxides | 1 | 2010 | 21 | 0.320 |
Why?
|
| Glycosides | 1 | 2010 | 22 | 0.320 |
Why?
|
| Porifera | 1 | 2010 | 15 | 0.320 |
Why?
|
| Phytotherapy | 2 | 2007 | 78 | 0.310 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 295 | 0.310 |
Why?
|
| Liver Neoplasms | 2 | 2025 | 211 | 0.290 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2017 | 147 | 0.270 |
Why?
|
| Genome-Wide Association Study | 4 | 2024 | 421 | 0.270 |
Why?
|
| Mycobacterium marinum | 1 | 2007 | 7 | 0.270 |
Why?
|
| Models, Molecular | 3 | 2016 | 875 | 0.260 |
Why?
|
| Gene Regulatory Networks | 2 | 2025 | 143 | 0.260 |
Why?
|
| Isothiocyanates | 4 | 2023 | 20 | 0.260 |
Why?
|
| Cell Survival | 3 | 2024 | 934 | 0.240 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2015 | 300 | 0.240 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2018 | 62 | 0.240 |
Why?
|
| Molecular Conformation | 2 | 2016 | 157 | 0.230 |
Why?
|
| Abscisic Acid | 1 | 2025 | 6 | 0.230 |
Why?
|
| Sialyltransferases | 1 | 2024 | 2 | 0.220 |
Why?
|
| Biocatalysis | 1 | 2024 | 30 | 0.220 |
Why?
|
| Pseudogenes | 1 | 2024 | 12 | 0.220 |
Why?
|
| Oligosaccharides | 1 | 2024 | 28 | 0.220 |
Why?
|
| Hydrogels | 1 | 2025 | 55 | 0.220 |
Why?
|
| Dextran Sulfate | 1 | 2024 | 17 | 0.220 |
Why?
|
| Milk, Human | 1 | 2024 | 51 | 0.210 |
Why?
|
| Wound Healing | 1 | 2025 | 82 | 0.210 |
Why?
|
| Nitro Compounds | 1 | 2024 | 34 | 0.210 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 2598 | 0.210 |
Why?
|
| Embryonic Development | 1 | 2024 | 83 | 0.210 |
Why?
|
| Moths | 1 | 2023 | 13 | 0.210 |
Why?
|
| Thiazoles | 1 | 2024 | 76 | 0.210 |
Why?
|
| Hydrogen Sulfide | 1 | 2025 | 77 | 0.210 |
Why?
|
| Colitis, Ulcerative | 1 | 2024 | 68 | 0.200 |
Why?
|
| MicroRNAs | 3 | 2025 | 501 | 0.200 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 94 | 0.200 |
Why?
|
| Crystallography, X-Ray | 2 | 2015 | 285 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2025 | 170 | 0.200 |
Why?
|
| Aldehydes | 1 | 2023 | 69 | 0.200 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 131 | 0.200 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2014 | 84 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 64 | 0.200 |
Why?
|
| Transcription Factors | 3 | 2025 | 722 | 0.200 |
Why?
|
| Hepatocytes | 1 | 2023 | 79 | 0.200 |
Why?
|
| Tumor Cells, Cultured | 4 | 2016 | 506 | 0.190 |
Why?
|
| Hepatitis B | 1 | 2022 | 41 | 0.190 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 126 | 0.190 |
Why?
|
| Body Weight | 1 | 2024 | 428 | 0.190 |
Why?
|
| Insulin | 1 | 2024 | 255 | 0.190 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 228 | 0.180 |
Why?
|
| Neutralization Tests | 1 | 2021 | 55 | 0.170 |
Why?
|
| Male | 11 | 2025 | 22779 | 0.170 |
Why?
|
| Biological Factors | 1 | 2000 | 6 | 0.170 |
Why?
|
| Mass Screening | 1 | 2025 | 531 | 0.170 |
Why?
|
| Trees | 1 | 2000 | 21 | 0.170 |
Why?
|
| Drug Resistance, Viral | 1 | 2020 | 67 | 0.160 |
Why?
|
| Hepacivirus | 1 | 2020 | 73 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2016 | 1420 | 0.160 |
Why?
|
| Mice, Inbred BALB C | 2 | 2024 | 686 | 0.160 |
Why?
|
| Genome, Human | 1 | 2020 | 143 | 0.150 |
Why?
|
| Prevalence | 2 | 2021 | 1597 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2020 | 138 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2024 | 860 | 0.150 |
Why?
|
| Myrica | 1 | 2018 | 1 | 0.150 |
Why?
|
| Quinolones | 1 | 2018 | 13 | 0.150 |
Why?
|
| Genome, Plant | 1 | 2018 | 29 | 0.150 |
Why?
|
| Antiviral Agents | 1 | 2020 | 189 | 0.140 |
Why?
|
| Female | 11 | 2025 | 24018 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2024 | 164 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 339 | 0.140 |
Why?
|
| pol Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 2 | 0.140 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 8 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2024 | 128 | 0.140 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 17 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2018 | 65 | 0.130 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 64 | 0.130 |
Why?
|
| HIV Infections | 2 | 2025 | 2535 | 0.130 |
Why?
|
| Genetic Variation | 1 | 2020 | 429 | 0.130 |
Why?
|
| Antitubercular Agents | 1 | 2017 | 33 | 0.130 |
Why?
|
| Flowers | 2 | 2018 | 20 | 0.130 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 53 | 0.130 |
Why?
|
| Risk Factors | 3 | 2021 | 3942 | 0.130 |
Why?
|
| Genome, Viral | 1 | 2017 | 118 | 0.130 |
Why?
|
| Phosphorylation | 2 | 2017 | 973 | 0.130 |
Why?
|
| Triazoles | 1 | 2017 | 100 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2018 | 299 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2016 | 884 | 0.130 |
Why?
|
| Iridoids | 1 | 2016 | 5 | 0.130 |
Why?
|
| Tuberculosis | 1 | 2017 | 76 | 0.130 |
Why?
|
| Histone Code | 1 | 2016 | 13 | 0.120 |
Why?
|
| Fermentation | 1 | 2016 | 38 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 106 | 0.120 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2016 | 54 | 0.120 |
Why?
|
| Cricetinae | 1 | 2016 | 241 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2016 | 165 | 0.120 |
Why?
|
| Endocytosis | 1 | 2016 | 117 | 0.120 |
Why?
|
| Fatty Acids | 1 | 2016 | 134 | 0.120 |
Why?
|
| Cyclooxygenase 2 | 2 | 2016 | 106 | 0.120 |
Why?
|
| Particle Size | 1 | 2016 | 267 | 0.110 |
Why?
|
| Hedera | 1 | 2014 | 1 | 0.110 |
Why?
|
| Zygophyllaceae | 1 | 2014 | 2 | 0.110 |
Why?
|
| Bone Transplantation | 1 | 2014 | 3 | 0.110 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2014 | 5 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 14 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2014 | 13 | 0.110 |
Why?
|
| Semaphorins | 1 | 2014 | 4 | 0.110 |
Why?
|
| Drug Carriers | 1 | 2016 | 169 | 0.110 |
Why?
|
| Glioma | 1 | 2015 | 92 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2016 | 348 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 144 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2014 | 57 | 0.110 |
Why?
|
| Arabinonucleosides | 1 | 2014 | 2 | 0.110 |
Why?
|
| Hemolysis | 1 | 2014 | 59 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 10 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2015 | 129 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 121 | 0.110 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 72 | 0.110 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 3 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 72 | 0.100 |
Why?
|
| Keratin-8 | 1 | 2013 | 2 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2013 | 46 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 534 | 0.100 |
Why?
|
| Kidney | 1 | 2016 | 363 | 0.100 |
Why?
|
| Cell Movement | 1 | 2017 | 640 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 140 | 0.100 |
Why?
|
| Drug Discovery | 1 | 2014 | 106 | 0.100 |
Why?
|
| Base Sequence | 4 | 2017 | 997 | 0.100 |
Why?
|
| Hela Cells | 1 | 2014 | 370 | 0.100 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 66 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 158 | 0.090 |
Why?
|
| Prognosis | 2 | 2025 | 850 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1617 | 0.090 |
Why?
|
| Rhamnose | 1 | 2011 | 2 | 0.090 |
Why?
|
| Hepatitis B virus | 2 | 2022 | 18 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 330 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2013 | 452 | 0.090 |
Why?
|
| Caco-2 Cells | 2 | 2024 | 59 | 0.080 |
Why?
|
| Middle Aged | 5 | 2025 | 11819 | 0.080 |
Why?
|
| Yeasts | 1 | 2010 | 20 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 979 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2016 | 933 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 98 | 0.080 |
Why?
|
| DNA, Viral | 2 | 2022 | 323 | 0.080 |
Why?
|
| Stroke | 1 | 2013 | 348 | 0.080 |
Why?
|
| Histones | 2 | 2024 | 194 | 0.080 |
Why?
|
| Phenols | 1 | 2010 | 102 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 1058 | 0.070 |
Why?
|
| Plants | 2 | 2023 | 114 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2023 | 633 | 0.070 |
Why?
|
| Neoplasms | 2 | 2012 | 1341 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2025 | 2111 | 0.070 |
Why?
|
| Seawater | 1 | 2007 | 53 | 0.070 |
Why?
|
| Adult | 5 | 2025 | 13458 | 0.070 |
Why?
|
| Injections | 1 | 2025 | 40 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2025 | 36 | 0.060 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2024 | 1 | 0.060 |
Why?
|
| Lactose | 1 | 2024 | 16 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2024 | 11 | 0.060 |
Why?
|
| Fucosyltransferases | 1 | 2024 | 9 | 0.060 |
Why?
|
| Respiratory Sounds | 1 | 2024 | 12 | 0.060 |
Why?
|
| Chitosan | 1 | 2025 | 52 | 0.050 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2024 | 22 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2025 | 65 | 0.050 |
Why?
|
| Arabidopsis Proteins | 1 | 2025 | 45 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 1554 | 0.050 |
Why?
|
| Hybrid Vigor | 1 | 2024 | 1 | 0.050 |
Why?
|
| Janus Kinase 2 | 1 | 2024 | 33 | 0.050 |
Why?
|
| Anticarcinogenic Agents | 1 | 2004 | 74 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2024 | 64 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2024 | 82 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2023 | 55 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2025 | 317 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2023 | 2 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2024 | 165 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2023 | 82 | 0.050 |
Why?
|
| Colon | 1 | 2024 | 118 | 0.050 |
Why?
|
| Aged | 3 | 2024 | 7982 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2023 | 35 | 0.050 |
Why?
|
| Breast Feeding | 1 | 2024 | 123 | 0.050 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2024 | 183 | 0.050 |
Why?
|
| DNA Primers | 2 | 2013 | 295 | 0.050 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2022 | 13 | 0.050 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2023 | 23 | 0.050 |
Why?
|
| Virus Internalization | 1 | 2023 | 36 | 0.050 |
Why?
|
| Rats | 2 | 2025 | 3701 | 0.050 |
Why?
|
| Brucea | 1 | 2002 | 1 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2025 | 297 | 0.050 |
Why?
|
| Computational Biology | 1 | 2025 | 324 | 0.050 |
Why?
|
| Pyrans | 1 | 2002 | 10 | 0.050 |
Why?
|
| Chromatin | 1 | 2023 | 179 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 303 | 0.050 |
Why?
|
| Seeds | 1 | 2002 | 46 | 0.050 |
Why?
|
| Mothers | 1 | 2024 | 212 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 94 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 266 | 0.050 |
Why?
|
| Disease Progression | 1 | 2024 | 661 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2015 | 1266 | 0.040 |
Why?
|
| Infant | 1 | 2024 | 1143 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2015 | 727 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2020 | 82 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2024 | 683 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2024 | 1516 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2020 | 88 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 1729 | 0.040 |
Why?
|
| Genotype | 1 | 2022 | 796 | 0.040 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2020 | 51 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2025 | 1737 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1804 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2018 | 141 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 508 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 198 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2018 | 146 | 0.040 |
Why?
|
| Thiocyanates | 1 | 1997 | 7 | 0.030 |
Why?
|
| Sulfoxides | 1 | 1997 | 17 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 1997 | 53 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1997 | 21 | 0.030 |
Why?
|
| Mutation | 1 | 2022 | 1169 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 103 | 0.030 |
Why?
|
| India | 1 | 1997 | 105 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 96 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 114 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 740 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 40 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2016 | 60 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 56 | 0.030 |
Why?
|
| Child | 1 | 2024 | 3381 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 33 | 0.030 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Thioredoxin Reductase 1 | 1 | 2015 | 1 | 0.030 |
Why?
|
| alpha Karyopherins | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2015 | 11 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 18 | 0.030 |
Why?
|
| Vimentin | 1 | 2015 | 38 | 0.030 |
Why?
|
| Caveolin 1 | 1 | 2015 | 33 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 122 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 81 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 95 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2014 | 23 | 0.030 |
Why?
|
| Finite Element Analysis | 1 | 2014 | 16 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 22 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 246 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 190 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 383 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 670 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 88 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2485 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 456 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 454 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 692 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 928 | 0.020 |
Why?
|
| Lipids | 1 | 2013 | 256 | 0.020 |
Why?
|
| Homosexuality, Male | 1 | 2017 | 483 | 0.020 |
Why?
|
| HIV-1 | 1 | 2017 | 747 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 98 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 136 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 167 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 457 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2002 | 102 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 4936 | 0.010 |
Why?
|